Stopped: Business decision
This protocol will collect real world EHR data to support the product development life cycle activities associated with developing the Major Adverse Cardiac Events (MACE) Clinical Decision Support (CDS) software. The data will also be utilized in subsequent clinical validation to support an FDA application and/or applications to other regulatory agencies as needed.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Performance Characteristics NPV (Negative Predictive Value), Specificity and Sensitivity
Timeframe: Within 30-days from the Emergency Department Visit with suspicion of ACS (Acute Coronary Syndrome)